Hypertension aggravated and Joint destruction


Joint destruction is found among people with Hypertension aggravated, especially for people who are female, 60+ old.

The study analyzes which people have Joint destruction with Hypertension aggravated. It is created by eHealthMe based on reports of 43 people who have Hypertension aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 17, 2022

43 people who have Hypertension Aggravated and Joint Destruction are studied.

What is Hypertension aggravated?

Hypertension aggravated (high blood pressure-aggravated) is found to be associated with 1,289 drugs and 587 conditions by eHealthMe.

What is Joint destruction?

Joint destruction (joint damage) is found to be associated with 535 drugs and 366 conditions by eHealthMe.

Number of Joint destruction in Hypertension aggravated reports submitted per year:

Would you have Joint destruction when you have Hypertension aggravated?

Gender of people who have Hypertension Aggravated and experienced Joint Destruction *:

  • female: 78.05 %
  • male: 21.95 %

Age of people who have Hypertension Aggravated and experienced Joint Destruction *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 23.33 %
  • 60+: 76.67 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 26 people, 60.47%
  2. High Blood Cholesterol: 9 people, 20.93%
  3. Pain: 6 people, 13.95%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 6.98%
  5. Psoriasis (immune-mediated disease that affects the skin): 3 people, 6.98%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 6.98%
  7. Diabetes: 2 people, 4.65%
  8. Depression: 2 people, 4.65%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.65%
  10. Insomnia (sleeplessness): 2 people, 4.65%

Common drugs taken by these people *:

  1. Arthrotec: 9 people, 20.93%
  2. Humira: 8 people, 18.60%
  3. Rituxan: 8 people, 18.60%
  4. Methotrexate: 5 people, 11.63%
  5. Celebrex: 4 people, 9.30%
  6. Lipitor: 4 people, 9.30%
  7. Enbrel: 4 people, 9.30%
  8. Atenolol: 4 people, 9.30%
  9. Clopidogrel: 3 people, 6.98%
  10. Micardis: 3 people, 6.98%

Common symptoms for these people *:

  1. Joint Pain: 14 people, 32.56%
  2. Joint Swelling: 14 people, 32.56%
  3. Arthropathy: 10 people, 23.26%
  4. Impaired Healing: 10 people, 23.26%
  5. Joint Stiffness: 9 people, 20.93%
  6. Ligament Disorder (disease of ligament): 9 people, 20.93%
  7. Ankle Deformity: 9 people, 20.93%
  8. Pain In Extremity: 8 people, 18.60%
  9. Wound Infection: 8 people, 18.60%
  10. Pain: 8 people, 18.60%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Joint destruction?

Check whether Joint destruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Joint destruction:

Common drugs associated with Joint destruction:

All the drugs that are associated with Joint destruction:

Common conditions associated with Joint destruction:

All the conditions that are associated with Joint destruction:

How the study uses the data?

The study is based on Joint destruction and Hypertension aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: